Over the past few years a number of poster have remarked that Leo has held the DILUTION in check. Part of this is due to DF footing the bill for the PHASE I study of KEVENTRIN. That also shows how much DF believed in the possiblities of KEVETRIN as a two year trial study is not cheap. There are other reason too but that one sticks in my mind the most.
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links